Wednesday, November 19, 2008

AstraZeneca - Pulmicort: generic worries

Astrazeneca shares fell over 4% Wednesday after the U.S. Federal Drug Administration approved a generic version of its asthma treatment Pulmicort Respules, sparking fears a generic version will now be launched.

No comments: